David H. Rowtich

Chief of Neontology at Howard Hughes Medical Institute, Inc.

David H. Rowtich

David H. Rowtich

Chief of Neontology at Howard Hughes Medical Institute, Inc.

Biography

David H. Rowitch, MD, PhD.Investigator.Howard Hughes Medical Institute.
Rowitch, Professor of Pediatrics and Neurosurgery at the University of California at San Francisco (UCSF), is a neonatologist who treats premature infants. His laboratory in the UCSF Institute for Regeneration Medicine investigates the biology of stem cells in the brain. He thinks it is time to change the standard of care for patients at high risk of developing cerebral palsy. To accomplish that, he is exploring the basic biology behind the disease and plans to translate that knowledge into treatments that will reach patients more quickly.

Overview
RelSci Relationships

3129

Number of Boards

2

Number of Awards

1

Contact Data
Trying to get in touch with David H. Rowtich? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals David H. Rowtich likely has professional access to. A relationship does not necessarily indicate a personal connection.

Vice President at Howard Hughes Medical Institute, Inc.

Relationship likelihood: Strong

Vice President & Executive Director, Janelia Research Campus at Howard Hughes Medical Institute, Inc.

Relationship likelihood: Strong

Managing Director-US Equities at Howard Hughes Medical Institute, Inc.

Relationship likelihood: Strong

Herrick Foundation Chair at St. Jude Children's Research Hospital, Inc.

Relationship likelihood: Strong

Professor & Chairman-Molecular Genetics Department at The University of Texas - Southwestern Medical Center

Relationship likelihood: Strong

Director, Sloan Kettering Institute at Memorial Sloan-Kettering Cancer Center

Relationship likelihood: Strong

Co-Founder at TARA Biosystems, Inc.

Relationship likelihood: Strong

President, Chief Executive Officer & Director at Memorial Sloan-Kettering Cancer Center

Relationship likelihood: Strong

Lab Member at Harvard University - Paul F. Glenn Laboratories for the Biological Mechanisms of Aging at Harvard Medical School

Relationship likelihood: Strong

Director at University of California, San Francisco - The George Williams Hooper Research Foundation

Relationship likelihood: Strong

Paths to David H. Rowtich
Potential Connections via
Relationship Science
You
David H. Rowtich
Chief of Neontology at Howard Hughes Medical Institute, Inc.
Education
PhD in Biochemistry

The University of Cambridge (informally known as Cambridge University or Cambridge) is a public research university located in Cambridge, United Kingdom. It is the second-oldest university in the English-speaking world (after the University of Oxford), and the seventh-oldest in the world.

BA

The University of California, San Diego (also referred to as UC San Diego or UCSD) is a public research university located in La Jolla, California, United States. Established in 1960 near the pre-existing Scripps Institution of Oceanography, UCSD is the seventh oldest of the 10 University of California campuses and offers over 200 undergraduate and graduate degree programs. UCSD is one of America's Public Ivy universities, which recognizes top public research universities in the United States.

MD

The University of California, Los Angeles School of Medicine known as the David Geffen School of Medicine at UCLA, is an accredited medical school located in Los Angeles, California, USA.

Boards & Committees
Member, Scientific Advisory Council
Current

The Cerebral Palsy International Research Foundation (CPIRF) is a not for profit 501(c)3 organization dedicated to funding research and educational activities directly relevant to discovering the cause, cure and evidence based care for those with cerebral palsy and related developmental disabilities. Since our founding in 1955, CPIRF has contributed more than $40 million for research grants to support approximately 500 research projects in the biomedical and clinical sciences and in bioengineering. The Foundation has provided guidance, funds and other resources to research programs in the United States, the Middle East, Canada, the UK, Australia, and Greece as part of its global commitment to research and medical discoveries. Our website offers access to over 160 “research fact sheets”, web casts of scientific workshops, current and past research projects as well as discussion forums regarding treatments currently available for CP. CPIRF also contributes to national and international meetings and organizes scientific workshops designed to identify research opportunities and provide state of the art knowledge concerning CP prevention, cure and care.

Member, Scientific Advisory Board
Prior - 2018

St. Jude is unlike any other pediatric treatment and research facility. Discoveries made here have completely changed how the world treats children with cancer and other catastrophic diseases. With research and patient care under one roof, St. Jude is where some of today's most gifted researchers are able to do science more quickly. The mission of St. Jude Children’s Research Hospital is to advance cures, and means of prevention, for pediatric catastrophic diseases through research and treatment. Consistent with the vision of our founder Danny Thomas, no child is denied treatment based on race, religion or a family's ability to pay. Our vision is to be the world leader in advancing the treatment and prevention of catastrophic diseases in children. This vision will be pursued by providing outstanding patient care; by conducting basic, translational and clinical research designed to elucidate biological mechanisms, understand disease pathogenesis, improve diagnosis, enhance treatment outcome, prevent diseases and minimize adverse consequences of treatment; and by educating health care and scientific research professionals. Through these efforts we seek to cure and enhance the quality of life for an increasing proportion of children who come to us for treatment, and by expanding and sharing knowledge, to advance treatment of children with catastrophic diseases worldwide, while developing strategies to prevent catastrophic diseases in children.

Awards & Honors
Kimmel Scholar Award
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by David H. Rowtich. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of David H. Rowtich's profile does not indicate a business or promotional relationship of any kind between RelSci and David H. Rowtich.